Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Celebrating a decade of pharmacist vaccination
No longer the profession which ‘didn't touch people’, pharmacists are now one of Australia's leading vaccinators.
The operational pharmacist
Daniel Gilbertson is a pharmacist with a mind for business. Now the head of healthcare operating models at Medibank, he previously worked as a...
Moderna bolsters Australia’s vaccination campaign
Young and vaccine-hesitant patients are seeking out Modern's Spikevax in states with the lowest vaccination rates – Western Australia and Queensland
Facing the future of pharmacy
Pharmacists in Australia are now predominantly young and female, with 5–10 years’ experience and moving into leadership roles at a rate not previously seen in the profession.
Victoria’s SafeScript means changes for pharmacists
Community pharmacists in Victoria have less than three months to ensure they have an active connection with a Prescription Exchange Service (PES), so they...
Government prepares with COVID-19 pandemic plan
A new emergency response plan outlines Australia’s approach to containing COVID-19, as clusters of the novel coronavirus continue to emerge around the world.
